Showing results (11-20 of 403) with videos related to

Sort By:
Pageof 41
Journal of Chromatography. B, Biomedical Sciences and Applications|January 12, 2000
High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studiesA H Groll, D Mickiene, K Werner, et al.
Medical Mycology|February 24, 2001
New targets and delivery systems for antifungal therapyT J Walsh, M A Viviani, E Arathoon, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbitsA H Groll, B M Gullick, R Petraitiene, et al.
Mycoses|April 15, 2003
Itraconazole--perspectives for the management of invasive aspergillosisA H Groll
Antimicrobial Agents and Chemotherapy|October 3, 1999
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbitsA H Groll, V Petraitis, R Petraitiene, et al.
The Journal of Infectious Diseases|July 7, 2000
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous systemA H Groll, N Giri, V Petraitis, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbitsA H Groll, D Mickiene, V Petraitis, et al.
The Pediatric Infectious Disease Journal|August 26, 2000
Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factorsC C Chiou, A H Groll, C E Gonzalez, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma samplingA H Groll, D Mickiene, R Petraitiene, et al.
Klinische Padiatrie|April 29, 2005
New antifungal drugs and the pediatric cancer patient: current status of clinical developmentA H Groll, T Lehrnbecher
Pageof 41